![]() |
|||
|
|
|
|
| UPDATE: May 2008 | MW: 388.51 | MF: C16H17N2O5S•K |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
hamster
ovary
|
9 gm/L
|
NTPTR* NTP-TR-336,1988
|
cytogenetic analysis
|
human
lymphocyte
|
3 gm/L
|
MUTAEX 4,439,1989
|
mutation in microorganisms
|
mouse
lymphocyte
|
250 mg/L (+enzymatic activation step)
|
EMMUEG 12(Suppl 13),103,1988
|
sister chromatid exchange
|
hamster
ovary
|
500 mg/L
|
NTPTR* NTP-TR-336,1988
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | rat
lethal dose (50 percent kill): 1,124 mg/kg
|
N/R
|
PJPPAA 29,39,1977
|
intraperitoneal | mouse
lethal dose (50 percent kill): 1,351 mg/kg
|
N/R
|
NIIRDN 6,661,1982
|
intraperitoneal | rat
lethal dose (50 percent kill): 1,750 mg/kg
|
N/R
|
ARZNAD 12,751,1962
|
intravenous | mouse
lethal dose (50 percent kill): 1 gm/kg
|
N/R
|
ARZNAD 12,751,1962
|
oral | mouse
lethal dose (50 percent kill): >4 gm/kg
|
N/R
|
NIIRDN 6,661,1982
|
oral | rat
lethal dose (50 percent kill): >1,040 mg/kg
|
N/R
|
TXAPA9 18,185,1971
|
subcutaneous | mouse
lethal dose (50 percent kill): >4 gm/kg
|
N/R
|
NIIRDN 6,661,1982
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 16,250 mg/kg/13 week- intermittent
|
Gastrointestinal: Other changes
|
TXCYAC 56,123,1989
|
oral | rat
lowest published toxic dose: 195 gm/kg/13 week- intermittent
|
Gastrointestinal: Other changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXCYAC 56,123,1989
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
MUREAV 584,1,2005
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 82270; | Number of Industries 2; Total Number of Facilities 1,844; Number of Occupations 3; Total Number of Employees Exposed 3,026
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 82270 |
Number of Industries 2; Total Number of Facilities 301; Number of Occupations 11; Total Number of Employees Exposed 6,483; Total Number of Female Employees Exposed 3,052 | ||||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as a pharmaceutical and veterinary drug
|
NCI Carcinogenesis Studies (gavage);no evidence:mouse,rat
|
| ||||
REFERENCES:
CODEN
|
|
REFERENCE
ARZNAD
|
Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960
Aulendorf, Fed. Rep. Ger.) V.1- 1951-
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
MUTAEX
|
Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ,
UK) V.1- 1986-
|
NIIRDN
|
Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan)
|
NTPTR*
|
National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709)
No.206-
|
PJPPAA
|
Polish Journal of Pharmacology and Pharmacy. (ARS Polona, POB 1001, 00-068 Warsaw 1, Poland)
V.25-44, 1973-92. For publisher information, see PJPAE3
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
| |